Tag: Nasdaq:INZY

Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) today announced that it has postponed its 2025 Annual Meeting of Stockholders (the “Annual Meeting”), which was scheduled to be held on June 25, 2025, in light of the previously announced acquisition (the “Acquisition”) by BioMarin Pharmaceutical Inc. (“BioMarin”).

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsNasdaq:INZY

AsiaPay Partners with Tai Wo Management to Launch JOIE digital Payment Solution, Enhancing the Taxi Experience in Hong Kong

KBR ALERT: Bragar Eagel & Squire, P.C. is Investigating KBR, Inc. on Behalf of KBR Stockholders and Encourages Investors to Contact the Firm

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

Tag: Nasdaq:INZY

Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us